stockrow
Friday 6 November 2026
Export THC’s income statement to Excel — free account
Tenet Healthcare Corporation
THC Healthcare Medical Care Facilities
Tenet Healthcare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $21.3 billion, up 3.07% from fiscal 2024.
- Revenue
- +6.47%
- EPS
- +291.1%
- Free cash flow
- +39.2%
- Total debt
- +0.42%
Quarter to September 2026, against a year earlier
282.29
4.17
−1.46%
Follow THC
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
6.83 | 7.16 | 9.73 | 12.73 |
+8 more quarters Free account |
P/S ratio |
0.92 | 0.72 | 0.76 | 0.84 | |
P/FCF ratio |
6.15 | 5.17 | 4.89 | 7.08 | |
P/Operating CF |
15.99 | 26.71 | 9.98 | 24.51 | |
P/B ratio |
2.76 | 2.38 | 2.44 | 2.98 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.40 | 1.22 | 1.24 | 1.32 | |
EV/EBITDA |
4.35 | 4.25 | 5.14 | 6.42 | |
EV/Operating CF |
7.33 | 6.65 | 6.10 | 7.97 | |
EV/FCF |
9.33 | 8.83 | 7.95 | 11.15 | |
Quick Ratio |
0.99 | 0.86 | 0.91 | 1.22 | |
Current Ratio |
1.58 | 1.41 | 1.36 | 1.76 | |
Net Debt/EBITDA |
5.36 | 5.19 | 5.27 | 9.45 | |
Debt/Assets |
41.92% | 43.19% | 42.33% | 44.38% | |
Debt/Equity |
1.79 | 2.02 | 1.97 | 2.19 | |
Asset Turnover |
0.73 | 0.73 | 0.71 | 0.73 | |
Operating CF/Net income |
1.28 | 0.71 | 2.34 | 1.97 | |
Capex/Depreciation |
(0.89) | (0.76) | (0.77) | (1.54) | |
Interest Coverage |
8.62 | 9.38 | 8.34 | 4.16 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.41 | 0.41 | 0.41 | 0.42 | |
Share Based Compensation of Revenue |
0.62% | 0.78% | 0.47% | 0.45% | |
Graham Net Nets |
(0.77) | (1.04) | (0.98) | (0.88) | |
Graham Number |
279.20 | 214.80 | 183.69 | 153.11 | |
Earnings Yield |
14.65% | 13.96% | 10.28% | 7.86% | |
Free Cash Flow Yield |
16.25% | 19.35% | 20.45% | 14.12% | |
Revenue per Share |
70.27 | 67.38 | 61.84 | 61.31 | |
Operating CF per Share |
15.99 | 7.00 | 18.91 | 8.11 | |
Capex per Share |
(2.47) | (2.01) | (2.07) | (4.04) | |
Free Cash Flow per Share |
13.51 | 4.99 | 16.83 | 4.07 | |
Cash per Share |
33.37 | 25.98 | 34.18 | 31.98 | |
Shareholders Equity per Share |
92.53 | 78.50 | 77.34 | 66.74 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
92.53 | 78.50 | 77.34 | 66.74 | |
Free Cash Flow |
1,083.00 | 417.00 | 1,461.00 | 367.00 | |
Working Capital |
3,110.00 | 2,260.00 | 2,204.00 | 3,386.00 | |
Capital Expenditures |
(198.00) | (168.00) | (180.00) | (364.00) | |
Net Current Asset Value |
(15,749.00) | (16,292.00) | (16,134.00) | (15,811.00) | |
EV/EBIT |
4.99 | 4.98 | 6.23 | 8.04 | |
Capex to Sales |
0.04 | 0.03 | 0.03 | 0.07 | |
Price to Operating Income |
3.29 | 2.91 | 3.83 | 5.11 | |
| Other line items | |||||
Average Receivables |
2,556.50 | 2,570.50 | 2,612.00 | 2,550.50 | |
Average Payables |
1,371.50 | 1,365.50 | 1,333.00 | 1,327.00 | |
Average Inventory |
343.00 | 338.00 | 343.50 | 347.00 | |
Average Assets |
30,505.00 | 29,687.50 | 30,220.00 | 29,306.50 | |
Average Common Equity |
6,599.00 | 6,016.50 | 6,295.00 | 5,918.50 |
Columns are period end dates · fundamentals updated 2 Nov 2026